Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-12-11
2007-12-11
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S237000
Reexamination Certificate
active
10476743
ABSTRACT:
The invention discloses deuterated 3-piperidinopropiophenones as well as their physiologically tolerated salts. Furthermore, the invention concerns the use of deuterated 3-piperidinopropiophenones for the treatment of muscular illnesses as well as for the preparation of pharmaceutical drugs for the treatment of muscular illnesses.In addition, the invention discloses pharmaceutical formulations containing deuterated 3-piperidinopropiophenones as well as their physiologically tolerated salts for the treatment of muscular illnesses in addition to containing pharmaceutically tolerated adjuvants and/or additives.
REFERENCES:
patent: 3995047 (1976-11-01), Morita et al.
patent: 4638009 (1987-01-01), Itho et al.
patent: 24 58 638 (1975-06-01), None
Miyazaki et al, Kagaku no Ryoiki, Zokan, vol. 107, p. 133-137 (1975).
Axel Dietrich, “Tolperison: Alter Wirkstoff oder neue Leitstruktur” 1999, Dissertation, Paderborn XP002232677.
Alken Rudolf-Gisbert
Stabingis Thomas
BDD Berolina Drug Development GmbH
Dentz Bernard
Kriegsman & Kriegsman
LandOfFree
Deuterated 3-piperidinopropiophenone and medicaments... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Deuterated 3-piperidinopropiophenone and medicaments..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Deuterated 3-piperidinopropiophenone and medicaments... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3849734